Alzheimer's disease progression slowed by new drug | Alzheimer's
Study shows cognition in early-stage patients on lecanemab declines by 27% less than those on placebo
United Kingdom Rob Howard Jon Schott Susan Kohlhaas Alzheimer Research United Kingdom University College London
Source: theguardian.com